首页 | 本学科首页   官方微博 | 高级检索  
     

微生态制剂丽珠肠乐治疗肝硬化腹泻临床观察
引用本文:冯正平,叶伟生. 微生态制剂丽珠肠乐治疗肝硬化腹泻临床观察[J]. 热带医学杂志, 2002, 2(1): 52-53
作者姓名:冯正平  叶伟生
作者单位:广州市增城人民医院,广州,511300
摘    要:目的 研究微生态制剂丽珠肠乐治疗肝硬化腹泻的疗效。方法 采用前瞻性研究方法,将1998年4月对2001年7月63例肝泻患者随机分为治疗组及对照两组,治疗组(n=32)服用丽珠肠乐治疗,对照组(n=31)服用氧氟沙星治疗,分别观察其腹泻好转情况。结果 治疗组总有效率是93.72%,而对照组总有效率是54.85%,两组间有显著性差异(P<0.05)。结论 微生态制剂丽珠肠乐治疗肝硬化腹泻疗效显著。

关 键 词:微生态制剂 丽珠肠乐 肝硬化 腹泻 治疗
文章编号:0254-900X(2002)01-0052-02
修稿时间:2002-01-10

Clinical observation of treating hepatocirrhosis diahrrhea with Micro-ecological production P.O.Bifidobiogcn
Feng Zhengping,Yie Weisheng People's Hospital Zengcheng city,Guangzhou. Clinical observation of treating hepatocirrhosis diahrrhea with Micro-ecological production P.O.Bifidobiogcn[J]. Journal Of Tropical Medicine, 2002, 2(1): 52-53
Authors:Feng Zhengping  Yie Weisheng People's Hospital Zengcheng city  Guangzhou
Affiliation:Feng Zhengping,Yie Weisheng People's Hospital Zengcheng city,Guangzhou 511300
Abstract:Objective To study the effect of P.O.Bifidobiogen treating diahrrhea caused by hepatocirrhosis.Method With a prospective research approach, 63 people who suffered from hepatocirrhosis diahrrhea were randomly divided into two groups: the treated group (n=32) taking P.O.Bifidobiogen and the contrast group (n=31) taking Ofloxacin, so that the effect of the two drugs on treating the diahrrhea of the two groups of subjects were respectively observed.Result A total curative effect of 93.72% was experienced by the treated group, and 54.85% by the contrast group, which indicates a remarkable difference (P<0.05) between the two groups.Conclusion P.O.Bifidobiogen bears a notable curative effect in treating hepatocirrhosis diahrrhea.
Keywords:micro-ecological production  P.O.Bifidobiogen  hepatocirrhosis  diahrrhea
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号